Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study - eBioMedicine
(PDF) Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal
Prognostic Impact of Serum Immunoglobulin Heavy/Light Chain Ratio in Patients with Multiple Myeloma in Complete Remission after Autologous Stem Cell Transplantation - Biology of Blood and Marrow Transplantation
Serum free light chain is associated with histological activity and cirrhosis in patients with chronic hepatitis B - ScienceDirect
The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases - ScienceDirect
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Serum-free light-chain assay: clinical utility and limitations - Malini V Bhole, Ross Sadler, Karthik Ramasamy, 2014
Cureus | Light-Chain Multiple Myeloma: A Diagnostic Challenge | Article
Manni Mohyuddin on X: "130!!!! So thats how high the kappa light goes! And hence,an adjusted kappa/lambda ratio from "0.26 to 1.65" to "0.37 to 3.1" has been suggested to better pick
Laboratory testing in the evaluation of a monoclonal protein: A practical framework for interpretation